Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Chellaiah, Meenakshi A ^a   Ma, Tao ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; HERMES ANTIGEN; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; CD44 PROTEIN, MOUSE; MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; PROTEIN BINDING; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL POLARITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; ANIMAL; C57BL MOUSE; CELL MEMBRANE; CELL MIGRATION ASSAY; CELL MOTION; CYTOLOGY; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENE SILENCING; IMMUNOBLOTTING; METABOLISM; MOLECULAR WEIGHT; OSTEOLYSIS; PATHOLOGY; PROTEIN TRANSPORT;

ANIMALS; ANTIGENS, CD44; BONE RESORPTION; CELL MEMBRANE; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL POLARITY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE KNOCKDOWN TECHNIQUES; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; OSTEOCLASTS; PROTEIN BINDING; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84883194417     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/302392     Document Type: Article

References (55)

1. Yu X., Collin-Osdoby P., Osdoby P., SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity. Connective Tissue Research 2003 44 supplement 1 79 84 2-s2.0-0037238103
2. Blavier L., Delaissé J. M., Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. Journal of Cell Science 1995 108 part 12 3649 3659 2-s2.0-0029616246
3. Spessotto P., Rossi F. M., Degan M., Francia R. D., Perris R., Colombatti A., Gattei V., Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. Journal of Cell Biology 2002 158 6 1133 1144 2-s2.0-0037119966 10.1083/jcb.200202120
4. Nyman J. S., Lynch C. C., Perrien D. S., Thiolloy S., O'Quinn E. C., Patil C. A., Bi X., Pharr G. M., Mahadevan-Jansen A., Mundy G. R., Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone. Journal of Bone and Mineral Research 2011 26 6 1252 1260 2-s2.0-79958859696 10.1002/jbmr.326
5. Engsig M. T., Chen Q.-J., Vu T. H., Pedersen A.-C., Therkidsen B., Lund L. R., Henriksen K., Lenhard T., Foged N. T., Werb Z., Delaisse J.-M., Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. Journal of Cell Biology 2000 151 4 879 889 2-s2.0-0034645060 10.1083/jcb.151.4.879
6. Vu T. H., Shipley J. M., Bergers G., Berger J. E., Helms J. A., Hanahan D., Shapiro S. D., Senior R. M., Werb Z., MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypetrophic chondrocytes. Cell 1998 93 3 411 422 2-s2.0-0346963598 10.1016/S0092-8674(00)81169-1
7. Sato T., Ovejero M. D. C., Hou P., Heegaard A.-M., Kumegawa M., Foged N. T., Delaissé J.-M., Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. Journal of Cell Science 1997 110 part 5 589 596 2-s2.0-0343554712
8. Irie K., Tsuruga E., Sakakura Y., Muto T., Yajima T., Immunohistochemical localization of membrane type 1-matrix metalloproteinase (MT1-MMP) in osteoclasts in vivo. Tissue and Cell 2001 33 5 478 482 2-s2.0-0035181911 10.1054/tice.2001.0201
9. Lesley J., Hyman R., CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. European Journal of Immunology 1992 22 10 2719 2723 2-s2.0-0026801075 10.1002/eji.1830221036
10. Weber G. F., Ashkar S., Cantor H., Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proceedings of the Association of American Physicians 1997 109 1 1 9 2-s2.0-0030941056
11. Thalmann G. N., Sikes R. A., Devoll R. E., Kiefer J. A., Markwalder R., Klima I., Farach-Carson C. M., Studer U. E., Chung L. W. K., Osteopontin: possible role in prostate cancer progression. Clinical Cancer Research 1999 5 8 2271 2277 2-s2.0-0032784057
12. Goodison S., Urquidi V., Tarin D., CD44 cell adhesion molecules. Journal of Clinical Pathology 1999 52 4 189 196 2-s2.0-0032768970
13. Seiki M., Mori H., Kajita M., Uekita T., Itoh Y., Membrane-type I matrix metalloproteinase and cell migration. Biochemical Society Symposium 2003 70 253 262 2-s2.0-1942508193
14. Johnson C., Galis Z. S., Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 54 60 2-s2.0-0347192989 10.1161/01.ATV.0000100402.69997.C3
15. Chellaiah M. A., Hruska K. A., The integrin α v β 3 and CD44 regulate the actions of osteopontin on osteoclast motility. Calcified Tissue International 2003 72 3 197 205 2-s2.0-0042855996 10.1007/s00223-002-1025-6
16. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., Seiki M., Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. Journal of Cell Biology 2001 153 5 893 904 2-s2.0-0035947766 10.1083/jcb.153.5.893
17. Chellaiah M. A., Kizer N., Biswas R., Alvarez U., Strauss-Schoenberger J., Rifas L., Rittling S. R., Denhardt D. T., Hruska K. A., Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Molecular Biology of the Cell 2003 14 1 173 189 2-s2.0-12244312775 10.1091/mbc.E02-06-0354
18. Chellaiah M. A., Biswas R. S., Rittling S. R., Denhardt D. T., Hruska K. A., Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts. Journal of Biological Chemistry 2003 278 31 29086 29097 2-s2.0-0042707709 10.1074/jbc.M211074200
19. Cao J. J., Singleton P. A., Majumdar S., Boudignon B., Burghardt A., Kurimoto P., Wronski T. J., Bourguignon L. Y. W., Halloran B. P., Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. Journal of Bone and Mineral Research 2005 20 1 30 40 2-s2.0-21644480869 10.1359/jbmr.2005.20.1.30
20. Samanna V., Ma T., Mak T. W., Rogers M., Chellaiah M. A., Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. Journal of Cellular Physiology 2007 213 3 710 720 2-s2.0-35848958379 10.1002/jcp.21137
21. Abécassis I., Olofsson B., Schmid M., Zalcman G., Karniguian A., RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Experimental Cell Research 2003 291 2 363 376 2-s2.0-0344010182 10.1016/j.yexcr.2003.08.006
22. Yu Q., Stamenkovic I., Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes and Development 1999 13 1 35 48 2-s2.0-0032926177
23. Zucker S., Drews M., Conner C., Foda H. D., DeClerck Y. A., Langley K. E., Bahou W. F., Docherty A. J. P., Cao J., Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). Journal of Biological Chemistry 1998 273 2 1216 1222 2-s2.0-0031984868 10.1074/jbc.273.2. 1216
24. Zhong J., Gencay M. M. C., Bubendorf L., Burgess J. K., Parson H., Robinson B. W. S., Tamm M., Black J. L., Roth M., ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. Journal of Cellular Physiology 2006 207 2 540 552 2-s2.0-33645657833 10.1002/jcp.20605
25. Hernandez-Barrantes S., Shimura Y., Soloway P. D., Sang Q. A., Fridman R., Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Biochemical and Biophysical Research Communications 2001 281 1 126 130 2-s2.0-0034815617 10.1006/bbrc.2001.4323
26. Bigg H. F., Morrison C. J., Butler G. S., Bogoyevitch M. A., Wang Z., Soloway P. D., Overall C. M., Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase a via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Research 2001 61 9 3610 3618 2-s2.0-0035328844
27. Dew G., Murphy G., Stanton H., Vallon R., Angel P., Reynolds J. J., Hembry R. M., Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone. Cell and Tissue Research 2000 299 3 385 394 2-s2.0-0034061370 10.1007/s004410050036
28. Itoh Y., Takamura A., Ito N., Maru Y., Sato H., Suenaga N., Aoki T., Seiki M., Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO Journal 2001 20 17 4782 4793 2-s2.0-0035801473 10.1093/emboj/20.17.4782
29. Toth M., Chvyrkova I., Bernardo M. M., Hernandez-Barrantes S., Fridman R., Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochemical and Biophysical Research Communications 2003 308 2 386 395 2-s2.0-0041592501 10.1016/S0006-291X(03)01405-0
30. Hoshino D., Tomari T., Nagano M., Koshikawa N., Seiki M., A novel protein associated with membrane-type1 matrix metalloproteinase binds p27kip1 and regulates RhoA activation, actin remodeling, and matrigel invasion. Journal of Biological Chemistry 2009 284 40 27315 27326 2-s2.0-70350451708 10.1074/jbc.M109.041400
31. Lal A., Haynes S. R., Gorospe M., Clean western blot signals from immunoprecipitated samples. Molecular and Cellular Probes 2005 19 6 385 388 2-s2.0-27744605030 10.1016/j.mcp.2005.06.007
32. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J. J. L., Ohashi P. S., Paige C. J., Gutierrez-Ramos J. C., Mak T. W., CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997 90 6 2217 2233 2-s2.0-0030796519
33. Chellaiah M. A., Regulation of podosomes by integrin α v β 3 and Rho GTPase-facilitated phosphoinositide signaling. European Journal of Cell Biology 2006 85 3-4 311 317 2-s2.0-33644943397 10.1016/j.ejcb.2006.01.008
34. Samanna V., Wei H., Ego-Osuala D., Chellaiah M. A., Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells. Experimental Cell Research 2006 312 12 2214 2230 2-s2.0-33745253734 10.1016/j.yexcr.2006.03.022
35. Desai B., Rogers M. J., Chellaiah M. A., Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Molecular Cancer 2007 6 article 18 2-s2.0-33947413459 10.1186/1476-4598-6-18
36. Le Q. T., Katunuma N., Detection of protease inhibitors by a reverse zymography method, performed in a tris(hydroxymethyl)aminomethane-Tricine buffer system. Analytical Biochemistry 2004 324 2 237 240 2-s2.0-0346992129 10.1016/j.ab.2003.09.033
37. Chellaiah M., Kizer N., Silva M., Alvarez U., Kwiatkowski D., Hruska K. A., Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. Journal of Cell Biology 2000 148 4 665 678 2-s2.0-0034695921 10.1083/jcb.148.4.665
38. Desai B., Ma T., Chellaiah M. A., Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. Journal of Biological Chemistry 2008 283 20 13856 13866 2-s2.0-46649093214 10.1074/jbc.M709401200
39. Deryugina E. I., Bourdon M. A., Luo G. X., Reisfeld R. A., Strongin A., Matrix metalloproteinase-2 activation modulates glioma cell migration. Journal of Cell Science 1997 110 part 19 2473 2482 2-s2.0-0031255124
40. Chellaiah M. A., Soga N., Swanson S., McAllister S., Alvarez U., Wang D., Dowdy S. F., Hruska K. A., Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. Journal of Biological Chemistry 2000 275 16 11993 12002 2-s2.0-0034697358 10.1074/jbc.275.16.11993
41. Strongin A. Y., Collier I., Bannikov G., Marmer B. L., Grant G. A., Goldberg G. I., Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. Journal of Biological Chemistry 1995 270 10 5331 5338 2-s2.0-0028907318 10.1074/jbc.270.10.5331
42. Desai B., Ma T., Zhu J., Chellaiah M. A., Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface. Journal of Cellular Biochemistry 2009 108 1 272 284 2-s2.0-76249122104
43. Yu Q., Stamenkovic I., Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF- β and promotes tumor invasion and angiogenesis. Genes and Development 2000 14 2 163 176 2-s2.0-0034650486
44. Hernandez-Barrantes S., Toth M., Bernardo M. M., Yurkova M., Gervasi D. C., Raz Y., Sang Q. A., Fridman R., Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. Journal of Biological Chemistry 2000 275 16 12080 12089 2-s2.0-0034697144 10.1074/jbc.275.16.12080
45. Hou P., Troen T., Ovejero M. C., Kirkegaard T., Andersen T. L., Byrjalsen I., Ferreras M., Sato T., Shapiro S. D., Foged N. T., Delaissé J.-M., Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption. Bone 2004 34 1 37 47 2-s2.0-0942268153 10.1016/j.bone.2003.08.011
46. Suenaga N., Mori H., Itoh Y., Seiki M., CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 2005 24 5 859 868 2-s2.0-13444273084 10.1038/sj.onc.1208258
47. Goebeler M., Kaufmann D., Bröcker E.-B., Klein C. E., Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. Journal of Cell Science 1996 109 part 7 1957 1964 2-s2.0-0029890062
48. Naor D., Sionov R. V., Ish-Shalom D., CD44: structure, function, and association with the malignant process. Advances in Cancer Research 1997 71 241 319 2-s2.0-0030966842
49. Okamoto I., Kawano Y., Tsuiki H., Sasaki J.-I., Nakao M., Matsumoto M., Suga M., Ando M., Nakajima M., Saya H., CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 1999 18 7 1435 1446 2-s2.0-0033580237
50. Okamoto I., Kawano Y., Murakami D., Sasayama T., Araki N., Miki T., Wong A. J., Saya H., Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. Journal of Cell Biology 2001 155 5 755 762 2-s2.0-0035956428 10.1083/jcb.200108159
51. Bourguignon L. Y., Gunja-Smith Z., Iida N., Zhu H. B., Young L. J., Muller W. J., Cardiff R. D., CD44v(3, 8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. Journal of Cellular Physiology 1998 176 206 215
52. Nakamura H., Suenaga N., Taniwaki K., Matsuki H., Yonezawa K., Fujii M., Okada Y., Seiki M., Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Research 2004 64 3 876 882 2-s2.0-0842347494 10.1158/0008-5472.CAN-03-3502
53. Hotary K. B., Yana I., Sabeh F., Li X.-Y., Holmbeck K., Birkedal-Hansen H., Allen E. D., Hiraoka N., Weiss S. J., Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. Journal of Experimental Medicine 2002 195 3 295 308 2-s2.0-0037017385 10.1084/jem.20010815
54. Fridman R., Toth M., Chvyrkova I., Meroueh S. O., Mobashery S., Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer and Metastasis Reviews 2003 22 2-3 153 166 2-s2.0-0038702661 10.1023/A:1023091214123
55. Nannuru K. C., Futakuchi M., Varney M. L., Vincent T. M., Marcusson E. G., Singh R. K., Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor- β signaling at the tumor-bone interface. Cancer Research 2010 70 9 3494 3504 2-s2.0-77951709842 10.1158/0008-5472.CAN-09-3251